Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01)

קרןNational Institute of Diabetes and Digestive and Kidney Diseases/NIH
סוגResearch Grants
תאריך אחרון26/02/2019
פקולטהLife Sciences, Medicine

This grant solicits applications for the Consortium on Targeting and Regeneration (CTAR) that supports the development of innovative strategies to increase or protect functional human beta cell mass in patients with Type-1 Diabetes (T1D) through the controlled manipulation of beta cell replication, islet cell plasticity, and the reprogramming of pancreatic non-beta cells into beta-like cells, or through shielding the residual beta cell mass from the autoimmune environment.


Funding: $550,000 per year 

Duration: 4 years


Research Authority due date: 20.1.19

LOI (encouraged) due date: 26.1.19

Full proposal due date: 26.2.19


קבצים מצורפים
עדכון אחרוןעדכון אחרון: 01/11/2018
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive